Impact of Peripheral Rabbit Anti-Thymocyte Globulin Without Heparin and Hydrocortisone Additives on Local Infusion Reactions

Background: Rabbit anti-thymocyte globulin (rATG) is indicated for induction immunosuppression therapy in renal transplant recipients. Heparin and hydrocortisone are standardly added to peripheral rATG preparations to reduce the incidence of local infusion reactions. In March 2023, this institution removed heparin and hydrocortisone additives in peripheral rATG preparations to avoid medication waste in the setting of drug shortages. Objective: The purpose of this study was to compare the incidence of local infusion reactions in renal transplant recipients receiving peripheral rATG with and without additives. Methods: This was a single-center, retrospective, pre- and post-implementation cohort study of adult renal transplant recipients. Patients were included if they were ≥18 years of age, received rATG through a peripheral line, and received a renal transplant between November 1, 2022 and July 12, 2023, inclusive. The primary outcome was the incidence of local infusion reactions. Descriptive statistics were used to report baseline demographics and a Fisher’s exact test was used to compare rates of local infusion reactions in the additives and no additives groups. Results: A total of 261 peripheral rATG doses were included in the analysis. The baseline characteristics were similar between the two groups. Of the 261 rATG infusions, 120 infusions included heparin and hydrocortisone in the preparation, while 141 of the infusions did not contain additives. The difference between groups in occurrence of local infusion reactions was not statistically significant. Local infusion reactions were reported during ten (8.3%) rATG infusions with additives compared to eight (5.7%) rATG infusions without additives ( P = .398). Conclusion: Renal transplant recipients receiving rATG induction therapy without heparin and hydrocortisone additives via peripheral infusion had a similar incidence of local infusion reactions compared to those with additives. Additional studies are needed to substantiate these findings.

Authors

Institutions

Publication Details

Journal
Hospital Pharmacy
Published
2026-07-16
DOI
https://doi.org/10.1177/00185787261467261
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Peripheral Rabbit Anti-Thymocyte Globulin Without Heparin and Hydrocortisone Additives on Local Infusion Reactions

Meagan Conrath, Kristen E. Marti, Leanna Borges, David M. O’Sullivan
Hospital Pharmacy
Renal Transplantation Outcomes and Treatments
article

Impact of Peripheral Rabbit Anti-Thymocyte Globulin Without Heparin and Hydrocortisone Additives on Local Infusion Reactions

Meagan Conrath, Kristen E. Marti, Leanna Borges, David M. O’Sullivan
article en

Abstract

Background: Rabbit anti-thymocyte globulin (rATG) is indicated for induction immunosuppression therapy in renal transplant recipients. Heparin and hydrocortisone are standardly added to peripheral rATG preparations to reduce the incidence of local infusion reactions. In March 2023, this institution removed heparin and hydrocortisone additives in peripheral rATG preparations to avoid medication waste in the setting of drug shortages. Objective: The purpose of this study was to compare the incidence of local infusion reactions in renal transplant recipients receiving peripheral rATG with and without additives. Methods: This was a single-center, retrospective, pre- and post-implementation cohort study of adult renal transplant recipients. Patients were included if they were ≥18 years of age, received rATG through a peripheral line, and received a renal transplant between November 1, 2022 and July 12, 2023, inclusive. The primary outcome was the incidence of local infusion reactions. Descriptive statistics were used to report baseline demographics and a Fisher’s exact test was used to compare rates of local infusion reactions in the additives and no additives groups. Results: A total of 261 peripheral rATG doses were included in the analysis. The baseline characteristics were similar between the two groups. Of the 261 rATG infusions, 120 infusions included heparin and hydrocortisone in the preparation, while 141 of the infusions did not contain additives. The difference between groups in occurrence of local infusion reactions was not statistically significant. Local infusion reactions were reported during ten (8.3%) rATG infusions with additives compared to eight (5.7%) rATG infusions without additives ( P = .398). Conclusion: Renal transplant recipients receiving rATG induction therapy without heparin and hydrocortisone additives via peripheral infusion had a similar incidence of local infusion reactions compared to those with additives. Additional studies are needed to substantiate these findings.

Hospital Pharmacy
Hartford Hospital (US), Hartford Financial Services (United States)
Openalex Percentile: Top 7%
Renal Transplantation Outcomes and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.